LOEILLOT OLIVIER (Chief Executive Officer) sold 16.4% of their position (7.04K shares) of REPLIGEN CORP on the open market
Open‑market sale worth $1.20M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/26/2025ACC: 0001193125-25-300642
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-7.04K
Net shares
Net seller
$1.20M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.04K
Price / share
$170.00
Trade value
$1.20M
% of position
16.4%
11/25/2025
42.94K→35.90K
Total
Net shares
−7.04K
Net value
-$1.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2025 | S · Sale | −7.04K | $170.00 | $1.20M | 16.4% | 42.94K | 35.90K |
| Total | −7.04K | -$1.20M | ||||||
Derivative Transactions0
No derivative transactions reported